Several peptides, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), activate the release of arachidonic acid (AA) and nitric oxide (NO) in endothelial cells (ECs). Both messengers are involved in EC proliferation and vascular permeability and control calcium homeostasis in different ways. Interestingly, it has been recently suggested that NO acts as a downstream mediator of AA-induced calcium entry in smooth muscle cells and isolated mouse parotid cells. In this paper, we have investigated the complex relationships that link intracellular calcium, AA, and NO in cultured endothelial cells. Using different experimental approaches, mainly simultaneous Ca 2+ and NO fluorimetric confocal imaging, we provide evidence for a complex pathway leading to noncapacitative calcium entry (NCCE) in bovine aortic endothelial cells (BAECs). In particular, AA is able to induce NCCE through two different pathways: one dependent on eNOS recruitment and NO release, the other NO-independent. Finally, we show that NO increase is involved in the control of BAEC proliferation.
eNOS. NO released by eNOS has a role in some of the key features of inflammation, such as cell rolling, adhesion and extravasation, as well as in modulating vascular permeability and angiogenesis in vivo (for a review, see Ref. 7) .
NO is an endothelial survival factor, inhibiting apoptosis (11, 12) ; it increases proliferation of some EC types and reduces it in others (13) (14) (15) (16) . NO also promotes endothelial cell migration (14, 17, 18) and enhances matrix-endothelial cell interaction (14, 15, 18) . NO acts as a vasodilator, and increased flow in the skeletal microcirculation has been observed to trigger endothelial cell proliferation (19) . Detailed mechanisms underlying the latter process are not known, but the modulation by NO of endothelial mechanically gated calcium-permeable channels activated by shear stress could be a critical route (20) .
Similarly, AA and the products of its metabolism (eicosanoids) act as autocrine or paracrine regulators of EC functions, particularly in inflammatory processes (21) . In ECs from bovine adrenal cortex capillaries, AA release and the lipoxygenase (LOX) pathway play a critical role in vascular cell proliferation induced by bFGF, PDGF, and serum (1) . In ECs isolated from bovine aorta, cytosolic phospholipase A2 (cPLA2) is activated by bFGF through p42 MAPK-dependent phosphorylation and triggers proliferation through the LOX pathway (22, 23) . Cyclooxygenase (COX) pathway is considered to be predominantly involved in the stimulation of migration (24) , even if recent evidence for an additional role of COX metabolism in EC proliferation has been provided in bovine aortic endothelial cells (BAECs) (25) .
Notwithstanding some significant differences in details, these data collectively suggest a common involvement of AA and NO in the regulation of biological events in which EC play a complex and critical role. Another shared feature is the association of the two messengers with intracellular calcium dynamics. Both AA and NO release are controlled, at least partially, by intracellular calcium elevation: several isoforms of cPLA2 and eNOS are calcium-dependent (26) (27) (28) . According to its association with the plasma membrane, eNOS has been proposed to be preferentially recruited by calcium entry rather than by calcium release from intracellular stores in BAECs (29) . Moreover, prolonged capacitative calcium entry strongly activates eNOS (30) . Nevertheless, it must be recalled that eNOS can be activated by calcium-independent additional mechanisms, such as PI3K-Akt signaling; similarly, AA can be released through calciumindependent pathways, either related or unrelated to PLA2 (11, 25, 31, 32) .
On the other hand, AA and NO themselves regulate intracellular calcium homeostasis, suggesting the presence of calcium-dependent feedbacks. In BAECs, AA induces a noncapacitative calcium entry (NCCE) that is involved in the control of cell proliferation and is probably carried through more than one type of calcium channels, whose molecular nature is not known (4, 33) . In these cells, the same mechanism is also activated by mitogenic growth factors, including bFGF and IGF-I (34).
Nitric oxide has been shown to affect intracellular calcium levels in ECs in different ways (9) . Flow-induced calcium entry, mediated by mechanically gated calcium-permeable channels, has been associated with a protein kinase G-activated conductance in rat aortic ECs (20) . In porcine pulmonary artery ECs (PAECs) NO both up-regulates the expression of cyclic nucleotide-gated channels and activates a cGMP-independent calcium entry (35, 36) . On the contrary, in calf pulmonary artery ECs (CPAECs), NO inhibits CCE and enhances endoplasmic reticulum uptake of calcium (6) .
Interestingly, NO has been recently proposed as a downstream mediator of AA-induced calcium entry in different cell types (37) (38) (39) . The main aim of this work is to verify this hypothesis in ECs.
The results obtained suggest that AA-induced calcium entry is due to the sum of NO-dependent and NO-independent mechanisms, pointing to a complex picture envisaging the existence of more than one mode for NCCE activation in ECs.
MATERIALS AND METHODS

Cell culture
Bovine aortic endothelial (BAEC) cells (European Collection of Cell Cultures, Salisbury, Wiltshire, UK) were maintained in Dulbecco's Modified Eagle's medium (DMEM, Sigma, St. Louis, MO, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS, Biowhittaker, Verviers, Belgium, lot 1SB0019), 50 μg/ml gentamycin and 4 mM glutamine, at 37°C, in a humidified atmosphere of 5% CO 2 in air. Cells were used at passages 2-6. Unless otherwise specified, all other reagents were obtained from Sigma.
RT-PCR
Total RNA was prepared from BAECs, maintained for 1-3 days in DMEM+1%FCS, using TriReagent (Sigma) and following manufacturer's instructions. After the precipitation step, RNA was treated with DNase I (Promega Corp., Madison, WI) to remove contaminating genomic DNA, then purified by phenol/chloroform extraction. One µg of total RNA was reversetranscribed into cDNA by using random hexameric primers (0.5 µg) and AMV reverse transcriptase (Reverse Transcription System, Promega). Aliquots of the cDNA products were used as templates for PCR amplification in a PE2400 thermal cycler (Perkin Elmer Corp., Wellesley, MA). Specific primers for bovine endothelial calcium-dependent NOS (GenBank accession n. NM181037), described by (40) , were 5′-GCTTGAGACCCTCAGTCAGG-3′ (left) and 5′-GGTCTCCAGTCTTGAGCTGG-3′ (right). Control mRNA for the metabolic enzyme hypoxanthine phosphoribosyltransferase (HPRT, GenBank accession n. AF176419) was amplified with the following primers: 5′-CCAGTCAACAGGCGACATAA-3′ (left) and 5′-AACACTTCGAGGGGTCCTTT-3′ (right).
Cycling conditions were 3 min at 94°C followed by 30 cycles of 1 min at 94°C/1 min at 55°C/1 min at 72°C, and a final extension of 7 min at 72°C. Control reactions were performed in the absence of cDNA. PCR products were separated on 2% agarose gels by electrophoresis and visualized by staining with ethidium bromide; images were acquired by a GelDoc apparatus (Bio-Rad Laboratories, Hercules, CA). Oligonucleotides were synthesized by Sigma Genosys.
Cell growth assay
Proliferation of BAECs was assessed by a colorimetric assay, as previously reported (25, 33) , following the method described by (41) , slightly modified. Briefly, BAECs were plated on noncoated plastic in 96-well plates (Falcon, Becton Dickinson, Franklin Lakes, NJ) in DMEM containing 10% FCS at a density of 800 cells/well. After 18 h, the medium was replaced with DMEM + 1% FCS, either alone (basal condition) or supplemented with different compounds able to induce an enzymatic (L-Arg) or pharmacological (sp/NO, SNAP) generation of NO. For each experiment, two plates were set up in which each condition was tested in 6 wells, in duplicate. One day later, endothelial cell number was estimated: cells were fixed in 2.5% glutaraldehyde in PBS for 20 min, then stained with crystal violet (0.1% in 20% methanol), solubilized in acetic acid (10%, v/v) and read at 595 nm in a Microplate Reader (model 550, BioRad). For each experiment, a calibration curve was set up with a known number of cells, and a linear correlation between absorbance and cell number was established, so that for each condition the mean number of cells ± SD was assessed.
Calcium measurements
Confocal fluorimetric measurements were performed using an Olympus Fluoview 200 laser scanning confocal system (Olympus America Inc., Melville, NY, USA) mounted on an inverted IX70 Olympus microscope, equipped with a ×60 oil-immersion objective (NA 0.17).
Cells were seeded on glass coverslips at a density of 5000 cells/cm 2 and growth arrested by shifting exponentially growing monolayers to DMEM containing 1% FCS 1-5 days before experiments. For calcium measurements the cells were loaded with Calcium Green 1 AM (2 µM, 30 min, 37°C) and excited by a 488-nm, 20-mW argon-ion laser. Emission signals were filtered by a 510-540 nm bandpass filter and detected with the scanning head.
For simultaneous calcium and NO measurements, cells were coloaded with Calcium Green 1 (see above) and DAR-4M AM (5 µM, 30 min, 37°C), and excited simultaneously at 488 and 568 nm. Emission signals were filtered by 510-540 nm (for Calcium Green 1) and 610 nm (for DAR-4M) bandpass filters and detected with the scanning head. For ratiometric measurements, cells were loaded with the acetoxymethyl ester form of indo-1 (2.5 μM indo-1 AM, 45 min at 37°C). The coverslips were placed on an inverted IM-35 Zeiss microscope with a ×100 fluorescence objective. Diaphragms were used to collect fluorescence from single cells. Fluorescence signals were taken at excitation wavelength of 380 nm and emissions of 400 and 480 nm using two spectrophotometers (Cairn Ltd, Newnham, UK). Cytosolic-free [Ca] i is expressed as a ratio (400/480) of emitted fluorescence, corrected for background and autofluorescence online.
cGMP assay
The levels of cGMP as an indirect measure of NO levels were evaluated using an enzymatic immunoassay (Biotrak EIA system, Amersham Biosciences, Uppsala, Sweden) following the manufacturer's instructions. Briefly, 10 5 BAECs were plated in each well of a 96-well plate in DMEM + 5% FCS for 24 h, then stimulated (or not, control conditions) with the different agonists, in duplicate, for 10 min at 37°C; for experiments in calcium-free medium, EGTA was added to DMEM + 5 % FCS in order to obtain a 3 mM final concentration, alone (control) or simultaneously with 5 µM AA (10 min at 37°C). Subsequently, the medium was removed, and cells were lysed with the supplied lysis reagent for 10 min. Aliquots of the samples were transferred from the cell culture plate on the immunoassay microplate and processed. Absorbance at 450 nm was read with a microplate reader (Bio-Rad).
Electrophysiology
BAE-1 cells were seeded at a density of 5000 cells/cm 2 in DMEM + 1% FCS for 1-5 days; they were flat, isolated, and firmly attached to the dish.
Whole-cell patch-clamp recordings were performed with an Axopatch 200B amplifier (Axon Instruments, Sunnyvale, CA). Electrodes (Clark Electromedical Instruments, Kent, UK) of 5-10 MΩ resistance were used. Data were filtered at 1 kHz, stored on a PCM video recorder, and sampled at 100 ms intervals (10 Hz). Voltage clamp protocols and off-line analysis were performed with pClamp 6 software (Axon Instruments). Instantaneous I-V relationships were obtained by applying voltage ramps (1 V/s) from -50 to +50 mV before SNAP perfusion and at the peak of the response.
External solutions were applied by a microperfusion system. The control solution was standard Tyrode described above for calcium measurements. When needed, the solution was exchanged with a standard Tyrode containing 5 μm of the NO donor SNAP. The composition of the All experiments were performed at 22-24°C.
Statistical analysis
One-way ANOVA (ANOVA) was performed to analyze sets of data. Post hoc tests were used to determine statistically significant differences among the groups (Student-Newman-Keuls test). The level of significance was P < 0.05.
RESULTS
Ca
2+ and NO elevation activated by AA stimulation
Recently, NO has been suggested to mediate AA-induced NCCE in smooth muscle cells and isolated mouse parotid cells (37, 38) . To verify this hypothesis in our cells, intracellular Ca 2+ and NO levels were simultaneously measured in BAECs stimulated with 5 µM AA after incorporation of Calcium Green 1 AM and DAR-4M AM, a cell-permeant fluorescent probe sensitive to NO and insensitive to pH (see Materials and Methods). To clarify the causal relationship connecting NO and Ca 2+ signals, the same experiment was performed in a calcium-free extracellular solution (0 Ca-3 mM EGTA) in order to abolish calcium influx, the only pathway of calcium increase in these cells induced by AA (33) . In these conditions, AA was still able to promote NO increment, unmasking a calcium-independent pathway for NO release ((ΔF/F 0 ) NO =0.65±0.13, 49 cells; Fig. 1B ).
The ability of AA to induce calcium increase in cells pretreated with thapsigargin (1 µM for 10 min), an inhibitor of SERCA that completely and irreversibly depletes intracellular calcium stores, confirmed that the response was entirely due to noncapacitative calcium entry ((ΔF/F 0 ) Ca =0.66±0.30, 32 cells; Fig. 1C ).
To verify a potential direct effect of AA on eNOS, we used ETYA (5,8,11,14-eicosatetraynoic acid), an acetylenic AA analog, which blocks all AA-metabolizing enzymes by acting as a false substrate. Application of 5 µM ETYA triggered NO increase, both in the presence and in the absence of calcium in the extracellular medium (respectively, (ΔF/F 0 ) NO =0.69±0.22 and 0.78±0.14, 28 and 20 cells; Fig. 1D ).
cGMP assay was performed to confirm this evidence. Stimulation with either 5 µM AA, 5 µM ETYA, 10 µM SNAP, 2 mM L-Arg significantly increased cGMP levels (n=4 ; Fig. 1E) ; consistent with the existence of a mechanism of NO release induced by AA in a calciumindependent way, cGMP levels were augmented also when AA was added to a medium containing 3 mM EGTA in order to prevent calcium influx.
These data suggest the ability of AA to activate NO release in a direct way, even if an additional effect of AA metabolites on eNOS cannot be excluded.
Bovine aortic endothelial cells express eNOS, as demonstrated by RT-PCR experiments (n=3; Fig. 1F ).
Calcium signals activated by NO in single BAECs
Recent data from different cell types, including ECs, suggest that NO is able to induce calcium signals (35-39) ; however, NO-dependent calcium entry inhibition has been also described (6) . For these reasons, we decided to analyze at the single-cell level the effects of NO on calcium signaling in BAECs. They were assessed by the use of either L-Arg (a widely used eNOS activator that enters the cell via a specific membrane carrier) or NO donors (NOC 18 and SNAP). Fig. 2B ). Moreover, it was completely due to calcium entry, as suggested by its complete inhibition in the presence of 3 mM external EGTA; subsequent calcium addition to the external bath completely restored the response to L-Arg (4 cells; Fig. 2C ).
Ratiometric calcium measurements using the indo-1 probe were performed in order to quantitatively test CCE and NCCE contribution to the response to L-Arg. 2 mM L-Arg was still able to induce calcium increase in cells pretreated with thapsigargin (TG, 1 µM for 10 min), confirming, as in the case of AA, that the response was entirely due to NCCE (R(400/480)=0.15±0.1 for controls, 9 cells, and 0.17±0.05 with TG, 8 cells; Fig. 2D ).
To exclude the possibility that NO-induced calcium entry was due to an effect on cPLA2 and indirectly to AA, cells were stimulated with L-Arg in the presence of a widely used cPLA2 inhibitor, AACOCF3 (preincubation with 5 µM AACOCF3 for 10 min): calcium entry could still be observed (18 cells; Fig. 2E ).
Stimulation with either 10 µM SNAP or 1 mM NOC18, two independent NO donors, triggered calcium increases very similar to those described for 2 mM L-Arg application, as shown in Fig.  1A ((ΔF/F 0 ) Ca =0.38±0.11 and 0.29±0.04, 28 and 24 cells, respectively; Fig. 3A, B) .
Eletrophysiological measurements performed in whole cell configuration, voltage clamp mode, confirmed the ability of SNAP to activate a cationic current with a V rev near 0 mV (n=4; Fig. 3C,  D) . Cl -involvement could be excluded, because V h =-50 mV corresponds to V Cl in the ionic conditions used (see external and internal solutions composition in Materials and Methods).
The next set of experiments was performed to investigate the possible involvement of guanylyl cyclase and cGMP as mediators of NO-induced calcium entry. We tested the effects of 8-BrcGMP, a membrane-permeable cGMP analog, and ODQ, a widely used guanylyl cyclase inhibitor.
Direct application of either 1 mM 8-Br-cGMP or 10 µM ODQ on resting cells failed to activate any calcium signal, and subsequent perfusion with 2 mM L-Arg induced a calcium entry undistinguishable from control experiments (90 and 12 cells, respectively; Fig. 4A ).
In cells pretreated with 10 µM ODQ for 10', stimulations with 2 mM L-Arg or 10 µM SNAP were still able to increase calcium levels (respectively (ΔF/F 0 ) Ca =0.41±0.18 and 0.31±0.12, 21 and 9 cells; Fig. 4B and C) .
Finally, acute application of 1 mM 8-Br-cGMP or 10 µM ODQ on the calcium increase induced by 2 mM L-Arg didn't exert any detectable effect (6 and 8 cells, respectively; Fig. 4D and E) .
AA induces calcium signals independently from NO
To evaluate whether AA-induced calcium signals were totally dependent on NO release, BAECs were pretreated with L-NAME (5 mM for 30 min) or L-NMMA (1 mM for 30 min), two unrelated and widely used eNOS inhibitors.
In these conditions, 5 µM AA was still able to increase calcium levels, showing the existence of a NO-independent calcium entry component ((ΔF/F 0 ) Ca =0.36±0.19 and (ΔF/F 0 ) Ca =0.33±0.08, for 36 and 20 cells; Fig. 5A, B) .
Ratiometric calcium measurements using indo-1 probe were performed in cells in order to quantitatively confirm this evidence: the amplitude of the calcium increase, expressed as R(400/480), in control cells stimulated with 5 µM AA was 0.33 ± 0.25 (8 cells), whereas in cells pretreated with L-NMMA, was 0.37 ± 0.24 (8 cells).
NO and cell proliferation
BAECs were plated in DMEM + 10% FCS for 18 h, then stimulated in DMEM + 1% FCS for 24 h, with or without (control) different agonists, which were able to induce an increase of NO levels, such as L-Arg (2 mM) or the NO donors sp/NO and SNAP, at different concentrations.
Stimulation with either L-Arg or low doses of NO donors induced a significant increase in cell number, as shown in the representative experiment in Fig. 6 . Considering all the experiments (n=10) as a whole and expressing the data as percentages of growth referred to the control condition (cells in DMEM+1% FCS, 100% of growth), values obtained under different conditions were the following: 2 mM L-Arg, 141.2±20.8%; 1 µM sp/NO, 145.3±17.1%; 1 µM SNAP, 159.0±29.4%; and 10 µM SNAP, 152.2±26.3%.
Higher doses of sp/NO (5, 10, 50 µM) caused a significant loss of cells, confirming earlier findings of proapoptotic effects described by several authors (42) . Also, high doses of SNAP (50 µM) inhibited proliferation as reported (43; data not shown).
DISCUSSION
Recent papers support the idea that NO mediates AA-induced NCCE in smooth muscle cells and isolated mouse parotid cells (37, 38) .
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ECs represent an interesting model to test the general validity of this hypothesis for several reasons: AA and NO are two critical intracellular messengers in these cells, and both are involved in the control of EC activation, proliferation, and motility, key events in angiogenesis and inflammatory processes (44, 45) . Their ability to promote calcium signals in different cell types, including ECs, has been well documented by several authors: in particular, we have previously shown that AA at low concentrations (such as those used in this work) activates a calcium entry entirely due to a noncapacitative mechanism in BAECs (4, 25, 33) . On the other hand, NO exerts opposite effects on different calcium channels and pumps in ECs (6, 9, 20, 35, 36) .
The major aims of this work were to study calcium signals activated by AA and NO in BAECs at the single cell level and to clarify the functional relationships between the related signaling pathways. The conclusions are summarized in Fig. 7 .
The first relevant finding is the ability of AA at low, mitogenic concentrations (5 µM; Ref. 33) , to induce a simultaneous increase in the concentrations of cytosolic calcium and NO in the same cell loaded with the two fluorescent indicators Calcium Green 1 and DAR-4M. Evidence for AA-mediated NO increase is strengthened by cGMP assays.
This effect could be explained by the simple assumption that NO increase is a direct consequence of AA-induced calcium increase, according to the reported calcium dependence of activation of membrane-associated eNOS (NOS III) and to the possibility that cPLA2, AA, eNOS, NO, and calcium channels are colocalized, potentially associated to caveolae, as proposed by several authors (46, 47) . However, calcium influx alone cannot account for the whole effect, since in the presence of a calcium-free external solution, leading to the complete abolition of calcium signals, AA-induced NO increase could still be observed in our preparation, indicating that at least a significant component of NO release is due to a calcium-independent, AAdependent mechanism. This hypothesis is confirmed by cGMP measurements, in which 5 µM AA application still induced cGMP production in a calcium-free external solution, but at a lower extent when compared with AA treatment in the presence of extracellular calcium; therefore, it is conceivable that in our model, AA-activated NCCE could reinforce eNOS recruitment, giving rise to a positive feedback.
AA-dependent NOS activation can be due to a direct effect of AA and (or) to the involvement of AA metabolites (eicosanoids). Cytochrome P450 AA epoxygenase metabolites, the epoxyeicosatrienoic acids (EETs), have been shown to stimulate EC growth and angiogenesis via MAP kinase, PI3 Kinase/Akt, and eNOS signaling pathways in BAECs (48) . EETs up-regulate eNOS synthesis and activity via MAPK-activation in the same cells (49) . Here, we show that AA-dependent NO release could be mimicked by the application of ETYA, an acetylenic AA analog, which blocks all AA-metabolizing enzymes by acting as a false substrate: this effect has been observed both at the single-cell level by the use of DAR-4M and at the population level by spectrophotometric cGMP measurements. This evidence suggests that at least a component of NOS recruitment could be due to AA itself. We do not know whether a direct AA-NOS interaction occurs or some other mediators are involved; moreover, the specificity of this effect on the different NOS types remains to be identified. This issue could be particularly relevant for inflammatory processes, in which the differential roles of iNOS and eNOS are still an object of debate (7).
After having shown that NO can be released via AA production, we analyzed the effect of NO on calcium homeostasis in BAECs.
NO donors (NOC18 and SNAP) and L-Arg, a well-known eNOS substrate and activator, triggered calcium signals very similar to those induced by AA, both in extent and in time course; they are entirely due to calcium entry from the extracellular medium, as suggested by the complete abolition of the response in the presence of extracellular EGTA and are noncapacitative because the pretreatment with thapsigargin, a widely used SERCA inhibitor able to deplete intracellular calcium stores, failed to exert any significant effect on NO-induced calcium rises.
The use of different and independent protocols for the induction of intracellular NO increase led us to exclude potential aspecific effects described for some NO donors, particularly concerning peroxynitrite pathways. Patch clamp measurements in whole cell configuration confirm the occurrence of NO-activated cation entry.
In other cell types, NO-induced calcium entry has been shown to be the result of a positive feedback on cPLA2 (50); however, this is not the case in our cells, as indicated by the ability of L-Arg to trigger calcium entry in the presence of AACOCF3, a cPLA2 inhibitor.
Subsequently, we addressed the issue of whether calcium entry is activated directly by NO or indirectly by NO-dependent intracellular processes. Because cGMP released by guanylate cyclase (GC) has been suggested to modulate calcium-permeable channels in ECs (6, 20, 37) , we tested this possibility by the use of ODQ, a well-known and widely used GC inhibitor, and 8-BrcGMP, a membrane-permeable cGMP analog. Application of these two compounds exerted no effects either on basal calcium levels or on L-Arg-activated signals. This observation points to the existence of cGMP-independent, NO-activated calcium channels responsible for NCCE in BAECs, according to the evidence provided in other cell types (35, 37) . We do not know the mechanism through which NO modulates the activity of ion channels in the plasma membrane. S-nitrosylation of critical thiol groups has been described as a mechanism responsible for ion channel modulation (51) (52) (53) ; the identification of the molecular nature of the calcium channels involved in AA-and NO-induced NCCE will allow us to test this hypothesis. Alternatively, other proteins or lipids may be involved as intermediary factors in NO-channel interaction.
Another interesting point to be addressed was the NO dependence of AA-induced calcium entry in our cells, as suggested for other cell types (35, 37) .
In cells pretreated with either L-NAME or L-NMMA, two independent eNOS inhibitors, AAinduced calcium increase was still detectable, suggesting that not all the calcium entry triggered by the fatty acid is mediated by NO. This evidence strengthens our previous observations in excised patches on the same cell type, in which direct application of AA triggered the opening of more than one calcium conductance: in these conditions, the involvement of eNOS/NO mediation is unlikely, even if the presence of membrane-associated eNOS cannot be completely excluded (33) .
Interestingly, AA-induced calcium rises in cells pretreated with NOS inhibitors were not significantly lower than in control experiments, suggesting that, in conditions in which NOdependent signaling is not active, NCCE directly activated by AA may be enhanced: in physiological conditions a cross regulation may occur between the two pathways, NO-dependent and NO-independent. A detailed single channel analysis will allow us to clarify this relevant topic: the aim should be to identify and distinguish calcium channels entirely activated either by AA or NO, and/or channels coregulated by the two messengers.
Finally, we have shown that intracellular NO increase, obtained either via eNOS recruitment (LArg) or via direct NO release by donors (sp/NO and SNAP), exerts a significant proliferative action on BAECs; a comparable mitogenic effect has been shown for AA stimulation on the same cells and in the same conditions by our group in a previous paper (33) , again suggesting a convergence of AA and NO pathways in these cells.
Collectively, our data suggest that in BAECs, the release of AA at low concentrations gives rise to a complex intracellular signaling network, including two distinct pathways for NCCE activation: one "shorter" and "directly" mediated by AA itself and another "longer" and mediated by NOS/NO recruitment (Fig. 7) . Because of the high heterogeneity of EC types (44), these two modes could act in parallel in the same cell or alternatively in physiological or pathological conditions; they may play different and specific roles in each endothelial cell type, depending on the tissue-dependent expression of intracellular factors (including NOS types and calcium channels). 
